A Long-term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia

Trial Profile

A Long-term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia

Completed
Phase of Trial: Phase II/III

Latest Information Update: 25 Aug 2015

At a glance

  • Drugs Cariprazine (Primary) ; Risperidone
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Sponsors Mitsubishi Pharma Corporation
  • Most Recent Events

    • 25 Aug 2015 According to an Allergan media release, pooled data from phase II/III studies will be presented at the 28th European College of Neuropsychopharmacology (ECNP) annual congress.
    • 19 Apr 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 27 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top